Telehealth Weight Loss/GLP-1 Prescribing: What Psychiatrists Can Do in California

You’ve seen the demand firsthand: patients on antipsychotics gaining 40 pounds, struggling with metabolic syndrome on top of their depression. Patients asking about ‘those weight-loss shots everyone’s talking about.’ Maybe you’ve wondered — is prescribing semaglutide or phentermine even in my lane?

Here’s the reality: yes, psychiatrists can prescribe weight-loss medications, and in many states, so can psychiatric nurse practitioners — but the rules are state-specific, sometimes strict, and the business case depends on understanding scope, telehealth regulations, and reimbursement.

This guide breaks down everything you need to know: who can prescribe what, state-by-state requirements for the six biggest telehealth markets (CA, TX, FL, NY, PA, IL), what the evidence says about psychiatrists managing GLP-1s, and how to make weight management a sustainable part of your practice — whether you’re seeing patients in-person or via telehealth.

Can Psychiatrists Prescribe GLP-1 Weight Loss Medications?

Short answer: Legally, yes. Practically, it depends on your training and comfort level.

Psychiatrists (MD/DO) have full prescriptive authority in all 50 states. Your medical license and DEA registration cover FDA-approved weight-loss medications — from older drugs like phentermine (Schedule IV stimulant) to newer GLP-1 receptor agonists like semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide.

The Scope Question: ‘Isn’t This Outside Psychiatry?’

Traditionally, yes — psychiatrists prescribe psychotropics, not metabolic drugs. But the lines are blurring fast, and for good reason.

The metabolic-psychiatric connection is real:

• Many psychiatric medications cause significant weight gain (antipsychotics, mood stabilizers, some antidepressants)
• Obesity worsens mental health outcomes and medication side effects
• GLP-1s show emerging evidence for mood benefits and craving reduction beyond just weight loss

Dr. Elliott Lewis, a psychiatrist who’s also board-certified in obesity medicine, puts it plainly: ‘If we truly understand that metabolic and mental health systems are inseparable, then psychiatrists being involved in metabolic treatment makes complete sense.’ You’re already monitoring metabolic labs for patients on Zyprexa or lithium — prescribing a medication to address weight gain ‘isn’t outside my scope…it’s part of comprehensive treatment’ when you have the competency.

What Does ‘Competency’ Look Like?

Scope of practice isn’t defined by your specialty title alone — it’s about training and competence. If you gained knowledge through:

• CME courses in obesity medicine or metabolic health
• Clinical mentorship with endocrinologists or obesity specialists
• Formal certification (e.g., American Board of Obesity Medicine — psychiatrists are eligible)

…then prescribing GLP-1s as part of holistic psychiatric care is defensible and increasingly common.

Many psychiatrists pursue dual certification in obesity medicine to solidify their scope. The ABOM certification requires ~60 hours of obesity-focused CME and passing a board exam. This signals to employers, insurers, and state boards that you’re not just ‘dabbling’ — you’re qualified to manage obesity as a chronic disease.

The Safety Evidence: No Increased Psychiatric Risk

A major concern was whether GLP-1s cause depression or suicidal ideation (media reports raised alarms). The data is reassuring:

• A 2025 meta-analysis in JAMA Psychiatry found no increase in depression or suicidality with GLP-1s versus placebo
• FDA and EMA reviews found no causal link to suicide risk
• Clinical trials (including the STEP studies for semaglutide) showed GLP-1-treated patients had slightly lower depressive symptoms compared to controls

In fact, weight loss itself improves mood and quality of life for many patients. Some psychiatrists report GLP-1s may help with binge eating and substance cravings, though that’s still early research.

Bottom line: With proper monitoring, psychiatrists can prescribe GLP-1s confidently. Document mental health screening at baseline, track mood alongside weight, and refer to primary care or endocrinology for complex metabolic issues.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Can Psychiatric Nurse Practitioners (PMHNPs) Prescribe Weight Loss Medications?

It depends entirely on your state and your scope of practice.

The State-by-State Patchwork

Unlike physicians, nurse practitioners face widely varying prescriptive authority depending on where they practice:

Full Practice Authority (FPA) States (~26 states + DC):NPs can prescribe weight-loss medications independently, including controlled substances like phentermine, without physician oversight. Examples: Washington, Oregon, Montana, Arizona, New Mexico, Colorado, Minnesota, Iowa, Nebraska, Alaska, Hawaii, Maryland, DC, Connecticut, Rhode Island, New Hampshire, Maine, Vermont.

Reduced Practice States (~20 states):NPs need a collaborative agreement with a physician for prescriptive authority, but can practice semi-independently after meeting experience requirements. Examples: New York (independent after 3,600 hours), Illinois (FPA available after 4,000 hours + training), Pennsylvania (collaboration required, no FPA yet), California (transitioning to FPA in 2026).

Restricted Practice States (~4 states):NPs must have physician supervision or delegation for all prescribing. Examples: Texas, Florida, Alabama, Georgia.

The Reality for PMHNPs Prescribing Weight-Loss Drugs

Even in FPA states, practical barriers exist:

1. Insurance and Pharmacy Pushback:Some insurers require a physician’s name on prior authorizations for expensive GLP-1s, even when not legally required. Pharmacies may call for ‘doctor approval’ for controlled substances or high-cost meds. This isn’t law, but it’s friction many independent NPs report.

2. Specialty Scope Concerns:Psychiatric NPs are trained in mental health, not metabolic disorders. State nursing boards expect NPs to practice within their education and competency. Prescribing weight-loss meds to psychiatric patients with medication-induced weight gain? That’s defensible. Running a standalone weight-loss clinic for the general population without additional training? That could raise questions.

3. Collaboration Requirements in Key States:

• Texas: All NPs need a Prescriptive Authority Agreement with a physician. The agreement must explicitly authorize weight-loss drugs (e.g., phentermine, GLP-1s). Physicians can supervise up to 7 NPs.
• Florida: NPs (called APRNs) must have a physician protocol agreement. Even ‘autonomous’ NPs (limited to primary care specialties, not psych) cannot prescribe controlled substances for weight loss independently.
• California: NPs currently need physician-standardized procedures. AB 890 is phasing in independence (full effect Jan 2026), but NPs still can’t independently prescribe controlled substances until they complete the transition period.
• New York: NPs need a collaborative agreement initially but can practice independently after 3,600 hours. Experienced PMHNPs can prescribe weight-loss meds solo, though payer rules may still require physician involvement.
• Pennsylvania: NPs must have a collaboration agreement (no FPA). Prescription blanks must include the collaborating physician’s name alongside the NP’s.
• Illinois: NPs can obtain FPA after 4,000 hours + 250 CE hours, allowing independent prescribing including controlled substances (with some Schedule II consultation requirements).

Practical Advice for PMHNPs

If you’re in a collaborative state (TX, FL, PA), you’ll need a physician medical director or collaborator who’s comfortable with weight management. This adds cost (physician oversight services range $2,000–$10,000/month depending on volume and risk), but it’s non-negotiable.

If you’re in an FPA state (or approaching it), you can prescribe independently — but consider:

• Supplemental training in obesity medicine (e.g., online CME courses, obesity management certifications)
• Focusing on patients where weight overlaps with psychiatric care (e.g., SSRI-induced weight gain, binge eating disorder)
• Partnering with a physician for complex cases or to smooth insurance credentialing

State-Specific Requirements: The Big Six Telehealth Markets

Telehealth weight-loss prescribing isn’t just about your scope — state laws on telehealth, controlled substances, and obesity treatment vary wildly. Here’s what you need to know for California, Texas, Florida, New York, Pennsylvania, and Illinois.

California

NP Scope:

• Currently ‘restricted’ — NPs need physician-standardized procedures to prescribe
• AB 890 phases in independence: Full practice authority begins Jan 1, 2026 for qualified NPs (after 3-year/4,600-hour transition)
• NPs cannot independently prescribe controlled substances until FPA is achieved

Physician Requirements:

• Strict Corporate Practice of Medicine (CPOM) doctrine: Only physicians can own medical practices
• Even with NP independence, weight-loss clinics often need physician medical directors to comply with CPOM

Prescribing Rules:

• No state-specific obesity prescribing regulations beyond standard of care
• Psychiatrists and NPs (with MD protocols) can prescribe GLP-1s and phentermine
• Follow FDA indications: BMI ≥30 or ≥27 with comorbidities

Telehealth:

• Very permissive telehealth laws — no special restrictions on remote prescribing
• Telehealth parity law requires insurers to reimburse telehealth equal to in-person (effective 2021)
• Out-of-state providers need a California medical/nursing license

Bottom Line for CA:By 2026, experienced PMHNPs will have more autonomy, but CPOM means physician involvement is often required at the business level. Psychiatrists have full authority. Telehealth is wide open.

Texas

NP Scope:

• Strict delegation state — all NPs need a Prescriptive Authority Agreement (PAA) with a Texas physician
• No path to independence; physician must oversee NP prescribing
• PAAs must detail which medications (including schedules) the NP can prescribe

Physician Requirements:

• Only Texas-licensed MDs/DOs can be medical directors
• Physicians can supervise up to 7 NPs/PAs in non-hospital settings
• Monthly quality review meetings and chart reviews required

Prescribing Rules:

• Schedule II stimulants (amphetamines) banned for weight loss in Texas
• Phentermine (Schedule IV) and GLP-1s are allowed with proper indication
• Must check Texas PMP for controlled substances
• No specific state obesity-treatment protocols, but standard of care applies

Telehealth:

• Telemedicine allowed; must establish patient relationship via adequate evaluation (video visit recommended)
• No state ban on controlled substance prescribing via telehealth (federal DEA waivers apply)
• Texas Medicaid reimburses telehealth at parity; private insurance coverage parity exists (payment parity advocated but not fully mandated)

Bottom Line for TX:NPs cannot practice independently — physician collaboration is mandatory and adds cost. Psychiatrists have full authority. Telehealth prescribing (including phentermine) is legal if standard of care is met.

Florida

NP Scope:

• APRNs must have physician protocol agreement (supervision)
• ‘Autonomous APRN’ status exists for primary care NPs (not psych) with 3,000+ hours, but autonomous NPs cannot prescribe controlled substances for weight loss
• PMHNPs will always need physician oversight in FL

Physician Requirements:

• Weight-loss clinics fall under Health Care Clinic Act — must have Florida-licensed physician as medical director
• One physician can supervise up to 4 APRNs (recently increased to 10 for PAs)

Prescribing Rules (Very Strict):

• Board of Medicine Rule 64B8-9.012 (mirrored for DOs) sets detailed obesity-prescribing standards:
• BMI ≥30 or ≥25 with comorbidity required
• Comprehensive physical exam and history required before prescribing (can be conducted by APRN under delegation)
• Written informed consent mandatory
• Patients must receive Weight-Loss Consumer Bill of Rights brochure
• Follow-up every 3 months minimum (face-to-face, telehealth acceptable)
• PDMP (E-FORCSE) check required before each controlled substance prescription
• Bans certain drugs (e.g., serotonergic anorectics not FDA-approved for obesity)

Telehealth Restrictions (Major Barrier):

• Florida prohibits controlled substance prescribing via telehealth except for:
• Psychiatric disorder treatment
• Inpatient/hospice care
• Acute pain treatment
• Weight loss is NOT an exception — phentermine cannot be prescribed via telehealth to FL patients
• GLP-1s (non-controlled) can be prescribed via telehealth if standard of care is met

Bottom Line for FL:Highly regulated. NPs need physician oversight. Phentermine via telehealth is illegal (state law trumps federal DEA waivers). GLP-1s via telehealth are allowed. Follow strict documentation and follow-up rules or face board discipline.

New York

NP Scope:

• ‘Reduced practice’ state — NPs need initial collaborative agreement with physician
• After 3,600 hours of practice (~2 years full-time), NPs can practice independently (NP Modernization Act)
• Experienced PMHNPs can prescribe weight-loss meds independently

Physician Requirements:

• No strict CPOM — NPs can own practices after meeting independence threshold
• Collaboration not required for experienced NPs

Prescribing Rules:

• No state-specific obesity prescribing regulations
• Follow standard of care (BMI criteria, informed consent, monitoring)
• I-STOP PMP check required before prescribing Schedule II–IV controlled substances (including phentermine)

Telehealth:

• Very supportive of telehealth — no controlled substance prescribing restrictions (follows federal law)
• Telehealth payment parity law effective Jan 2022 (commercial insurers must pay equal to in-person)
• Out-of-state providers need NY license

Bottom Line for NY:Experienced NPs have full independence. Psychiatrists have full authority. Telehealth is unrestricted. Strong parity laws make reimbursement favorable. Competitive market (many obesity specialists in NYC), so emphasize psychiatric angle.

Pennsylvania

NP Scope:

• ‘Collaborative’ state (reduced practice) — all CRNPs need collaboration agreement with physician to prescribe
• No FPA pathway yet (legislation proposed but not passed as of 2025)
• One physician can collaborate with up to 4 NPs

Physician Requirements:

• Collaborative agreement must outline prescribing authority (including drug categories)
• Physician must review charts regularly and be available for consultation
• Prescription blanks must include both the NP’s name and collaborating physician’s name

Prescribing Rules:

• No state-specific obesity treatment regulations
• Follow best practices (document BMI, labs, etc.)
• PA’s opioid prescribing law doesn’t affect weight-loss drugs (mostly non-opioid)

Telehealth:

• No state restrictions on controlled substance prescribing via telehealth (follows federal law)
• No comprehensive telehealth parity statute yet (some COVID-era expansions remain in place)
• Act 69 (2020) requires parity for tele-mental health services
• PA Medicaid reimburses telehealth similarly to in-person

Bottom Line for PA:NPs must have physician collaboration (no exceptions). Psychiatrists have full authority. Telehealth is allowed but parity not fully mandated. Rural areas may struggle to find collaborating physicians.

Illinois

NP Scope:

• Partial FPA state — APRNs can obtain Full Practice Authority after:
• ≥4,000 hours clinical experience
• ≥250 hours continuing education
• Application to remove collaborative agreement requirement
• APRNs with FPA can prescribe independently, including controlled substances (some Schedule II consultation requirements)
• Less experienced APRNs need collaborative agreement

Physician Requirements:

• Collaboration required for APRNs without FPA
• FPA-APRNs are fully independent (no physician needed)

Prescribing Rules:

• No state-specific obesity prescribing regulations
• All prescribers (MD and APRN) need separate Illinois Controlled Substance License to prescribe CS
• Illinois PMP check required for opioids (best practice for all controlled substances)

Telehealth:

• Strong telehealth support — Telehealth Alignment Act (2021) requires parity
• No state restrictions on controlled substance prescribing via telehealth
• Illinois Medicaid reimburses APRNs at 100% of physician rates (major financial incentive)

Bottom Line for IL:Best state for NP autonomy among the six. FPA-APRNs can prescribe independently. Psychiatrists have full authority. Excellent telehealth parity and Medicaid reimbursement. Growing market for weight management.

Telehealth Prescribing: Federal vs. State Rules

The telehealth prescribing landscape is a patchwork of federal waivers and state laws that can trap unwary providers.

Federal Law: DEA Waivers Extended Through 2025

The Ryan Haight Act normally requires an in-person exam before prescribing controlled substances. During COVID-19, this was waived. The DEA has extended telehealth flexibilities through December 31, 2025 (fourth extension), allowing providers to prescribe controlled substances (including phentermine) via telehealth without a prior in-person visit — if they conduct an adequate evaluation via audio-visual telemedicine.

But federal permission doesn’t override state bans.

State Bans on Controlled Substance Telehealth Prescribing

About 8 states have stricter rules than federal law, prohibiting or heavily restricting remote prescribing of controlled substances:

States That Ban Most Controlled Substance Telehealth Prescribing:

• Florida — controlled substances via telehealth banned except for psychiatric treatment, inpatient care, or acute pain. Weight loss is not an exception (phentermine illegal via telehealth in FL).
• Alabama — requires in-person exam for controlled substances
• South Carolina — strict telemedicine standards
• Idaho — mandates in-person exam for opioids or controlled weight-loss drugs

Even in states that allow it, providers must document a thorough evaluation (history, physical exam elements, discussion of risks/benefits) to meet standard of care.

GLP-1s Are Non-Controlled — Easier via Telehealth

The good news: semaglutide (Wegovy, Ozempic), liraglutide (Saxenda), and tirzepatide are not controlled substances. They can be prescribed via telehealth in all states as long as you:

• Establish a valid patient relationship (video visit recommended)
• Document appropriate indication (BMI criteria)
• Obtain informed consent
• Schedule follow-up monitoring

This is why many telehealth weight-loss startups focus on GLP-1s rather than phentermine — fewer legal landmines.

Reimbursement: Can You Get Paid for Weight Management?

Yes — and the landscape is improving rapidly.

Insurance Coverage for GLP-1 Weight-Loss Medications

A few years ago, weight-loss drugs were mostly cash-pay. Now:

• Most commercial insurers cover FDA-approved GLP-1s (Wegovy, Saxenda) with prior authorization
• Common PA requirements:
• BMI ≥30 or ≥27 with comorbidity
• Documentation of lifestyle interventions (diet, exercise)
• Comprehensive weight management plan (not just pills)
• Some insurers impose 30-day supply limits initially to monitor adherence (e.g., BCBS Texas)

Medicare/Medicaid Coverage (Game-Changer)

Historically, Medicare excluded weight-loss drugs entirely. In November 2025, the federal government announced Medicare will begin covering anti-obesity medications like Wegovy and Mounjaro — a monumental shift opening treatment to millions of seniors.

State Medicaid coverage varies (optional for states), but many are expanding coverage following Medicare’s lead.

What this means for providers:Patients who couldn’t afford GLP-1s out-of-pocket can now access them through insurance — increasing demand for qualified prescribers.

Billing for Weight Management Visits

Psychiatrists and PMHNPs can bill standard E/M codes for weight management consultations:

• Initial evaluation: 99202–99205 (new patient) or 90792 (psychiatric evaluation with med management) — Medicare pays ~$150–$200
• Follow-up visits: 99213–99215 (established patient, 15–40 minutes) — Medicare pays ~$75–$150

For obesity-focused counseling, you can also use:

• G0447 — 15 minutes face-to-face obesity counseling (Medicare, BMI ≥30)
• Time-based E/M coding if visit is primarily counseling

Telehealth Parity:Most states with parity laws require insurers to reimburse telehealth visits equal to in-person (CA, NY, IL have strong parity). Medicare continues to pay telehealth at office rates through at least 2025 (likely extending).

Psychiatrists vs. NPs: Reimbursement Gap

• Psychiatrists (MD/DO): Reimbursed at 100% of physician fee schedule by Medicare and most commercial insurers
• NPs: Medicare reimburses at 85% of physician rate when billed under NP’s NPI. Some private insurers pay 85–100%.
• Illinois exception: Illinois Medicaid reimburses APRNs at 100% of physician rates — unique and provider-friendly.

Economic reality: Even with the 85% rate, NPs are cost-effective. Lower salary costs offset slightly lower reimbursement. For platforms like Klarity, both MDs and NPs are profitable providers.

Documentation Tips for Reimbursement

To justify E/M codes and pass audits:

• Document BMI and comorbidities (obesity is ICD-10 E66.*)
• Note nutrition/exercise counseling provided
• Record informed consent discussion (risks, benefits, alternatives)
• Track response to treatment (weight change, side effects, labs)
• For controlled substances, document PMP check and clinical rationale

Proper documentation also aligns with state board requirements (e.g., Florida’s 3-month follow-up mandate).

The Business Case: Should You Add Weight Management to Your Practice?

Let’s talk economics.

Traditional DIY Marketing: Expensive and Uncertain

If you tried to build a weight-loss patient base yourself:

• SEO: Takes 6–12 months of consistent investment (blog posts, technical SEO, backlinks) before you see meaningful traffic. Cost: $2,000–$5,000/month for agency/consultant fees, plus your time. Uncertain ROI.
• Google Ads: Mental health and weight-loss keywords cost $15–40+ per click. A realistic cost per booked patient through PPC: $200–$400+ after accounting for wasted clicks, no-shows, and optimization time.
• Directory listings: Psychology Today, Zocdoc charge monthly fees ($30–$100+/month) AND you compete with hundreds of other providers. Zocdoc also charges per booking ($35–$100+). Total monthly cost adds up fast.
• Total DIY cost: Expect to spend $3,000–$5,000/month on marketing with uncertain results for the first 6–12 months.

Platform Model: Pay Only for Patients You See

Klarity Health uses a pay-per-appointment model similar to Zocdoc, but focused on psychiatry and mental health:

• No upfront marketing spend or monthly subscriptions
• You pay a standard listing fee per new patient lead who books with you
• Patients are pre-qualified — already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Economic advantage: Instead of gambling $3,000–$5,000/month on marketing that might not work, you pay only when a qualified patient books. Guaranteed ROI vs. uncertain spend.

Weight Management as a Growth Opportunity

Adding weight management to your psychiatric practice makes sense if:

• You see patients with medication-induced weight gain (antipsychotics, mood stabilizers)
• You’re interested in metabolic psychiatry or holistic care
• You’re willing to invest in training (obesity medicine CME, ABOM certification)
• You’re in a state with favorable telehealth/prescribing laws

Revenue potential: If you see 4 weight management patients per week at $100–$150 per follow-up visit (15–20 minutes each), that’s $1,600–$2,400/month in additional revenue with minimal time investment. GLP-1 refills are often quick check-ins (weight, side effects, dosage adjustment).

Platforms like Klarity remove the patient acquisition burden — you focus on clinical care, not marketing.

FAQ: Weight Loss Prescribing for Psychiatrists and PMHNPs

Q: Do I need special certification to prescribe GLP-1s?

No legal requirement, but additional training is highly recommended. Consider:

• CME courses in obesity medicine
• American Board of Obesity Medicine (ABOM) certification (psychiatrists are eligible)
• Clinical mentorship with endocrinologists

This strengthens your scope-of-practice defense and improves patient outcomes.

Q: Can I prescribe phentermine via telehealth?

Depends on your state:

• Allowed in most states during federal DEA waiver period (through Dec 31, 2025) if you conduct adequate video evaluation
• Banned in Florida (controlled substances via telehealth prohibited for weight loss), Alabama (requires in-person exam), and a few other states
• GLP-1s (non-controlled) can be prescribed via telehealth in all states with proper evaluation

Always check your state’s telehealth laws.

Q: What BMI criteria should I use for prescribing weight-loss medications?

Follow FDA labeling (which aligns with most state board expectations):

• BMI ≥30 (obesity), OR
• BMI ≥27 with weight-related comorbidity (diabetes, hypertension, sleep apnea, etc.)

Some states (Florida, New Jersey) mandate documenting BMI before prescribing — this isn’t optional.

Q: How often do I need to see patients for weight management?

State-specific:

• Florida: Every 3 months minimum (face-to-face, telehealth acceptable)
• Virginia: Monthly for first few months, then less frequent
• Other states: Follow standard of care — typically monthly initially to monitor response/side effects, then every 2–3 months for stable patients

Document all follow-ups for board compliance and billing.

Q: Can PMHNPs prescribe weight-loss medications independently?

State-dependent:

• Full Practice Authority states (e.g., New York after 3,600 hours, Illinois with FPA, Washington, Oregon): Yes, independently
• Collaborative states (Texas, Florida, Pennsylvania): No — need physician oversight via agreement/protocol
• Even in FPA states: Some insurers/pharmacies may require physician involvement for high-cost GLP-1s (practical barrier, not legal)

Check your state’s NP scope laws.

Q: Are there psychiatric benefits to GLP-1s beyond weight loss?

Emerging evidence suggests yes:

• Improved mood and quality-of-life scores (independent of weight loss)
• Possible reduction in cravings (substance use, binge eating)
• Anti-inflammatory effects that may influence brain health
• No increased depression or suicidality risk (2025 meta-analysis, FDA/EMA reviews)

Still early research, but promising for psychiatric populations.

Q: How do I handle insurance prior authorizations for GLP-1s?

Common PA requirements:

• Document BMI and comorbidities
• Show prior lifestyle interventions (diet, exercise)
• Provide comprehensive treatment plan (not just medication)
• Some insurers require specialist consultation or obesity medicine certification

Many telehealth platforms (including Klarity) handle PA submissions for providers — check what support is available.

Q: What’s the economic model for weight management on a telehealth platform?

Pay-per-appointment model (like Klarity):

• No upfront costs or monthly subscriptions
• Pay a standard listing fee per new patient lead who books
• You control your schedule and caseload
• Platform handles patient acquisition, credentialing, and infrastructure

DIY model (your own marketing):

• $3,000–$5,000/month in SEO, ads, directory listings
• 6–12 months before meaningful patient flow
• Realistic patient acquisition cost: $200–$500+ per booked patient
• Requires expertise, staff time, and patience

Platform advantage: Guaranteed ROI (pay only for patients you see) vs. gambling on marketing with uncertain results.

Next Steps: Join Klarity’s Provider Network

If you’re a psychiatrist or PMHNP interested in expanding into weight management — or simply want to see more psychiatric patients without the marketing headache — Klarity Health offers a smarter path forward.

What Klarity provides:

• Pre-qualified patient flow (insurance and cash-pay) matched to your specialty
• Built-in telehealth platform (no separate EMR/video costs)
• Pay-per-appointment model (no upfront spend, no wasted marketing budget)
• Credentialing support and state-by-state compliance guidance
• You control your schedule — part-time or full-time, your choice

Who we’re looking for:

• Licensed psychiatrists (MD/DO) in CA, TX, FL, NY, PA, IL (and expanding)
• Board-certified PMHNPs with prescriptive authority
• Providers interested in treating ADHD, anxiety, depression — and potentially weight management for psychiatric patients

Why providers join Klarity:Instead of spending $3,000–$5,000/month on marketing that might not work, you see patients from day one and pay only when they book. No risk. Guaranteed ROI. More time practicing medicine, less time chasing leads.

Ready to explore the platform? Visit Klarity Health’s provider page to learn more and apply.

Disclaimer: This content is for informational purposes only and does not constitute legal or medical advice. State regulations change frequently — always verify current laws with your state medical board or legal counsel. Scope of practice and prescribing authority are determined by state law and your individual training/competence.

References and Sources

1. MedicalDirector Co. — ‘How Much Does a Collaborative Physician Cost for Weight Loss, Telehealth, and Medspas? (2025 Definitive Guide)’ www.medicaldirectorco.com — Industry compliance guide (updated 2025)

2. MedicalDirector Co. — ‘Florida Weight Loss Clinic and Telehealth Compliance Guide (2025)’ www.medicaldirectorco.com — State-specific legal summary (updated 2025)

3. MedicalDirector Co. — ‘Texas Weight Loss Clinic & Telehealth Compliance Guide (2025)’ www.medicaldirectorco.com — State-specific legal summary (updated 2025)

4. Florida Administrative Code — Rule 64B15-14.004, ‘Standards for Prescription of Obesity Drugs’ www.law.cornell.edu — Official state regulation (effective Aug 8, 2022)

5. Foley & Lardner LLP (via Mondaq) — ‘A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ www.mondaq.com — Legal industry analysis (July 2023)

6. RxAgent.co — ‘Federal Permission, State Prohibition: The 2026 Telehealth Compliance Trap’ rxagent.co — Pharmacy compliance insights by PharmD (Dec 16, 2025)

7. The Nurse Practitioner Journal — ’36th Annual APRN Legislative Update: Improving Access and Removing Practice Barriers’ (Susanne J. Phillips) [journals.lww.com](https://journals.lww.com/tnpj/fulltext/2024/01000/36thannual

Source:

• https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/#:~:text=The%20answer%20is%20almost%20always,yes
• https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/#:~:text=Nurse%20Practitioners%20
• https://journals.lww.com/tnpj/fulltext/2024/01000/36thannualaprnlegislativeupdate__improving.6.aspx#:~:text=The%20Pennsylvania%20BON%20grants%20CRNPs%2C,more%20physicians%20to%20deliver%20healthcare
• https://journals.lww.com/tnpj/fulltext/2024/01000/36thannualaprnlegislativeupdate__improving.6.aspx#:~:text=The%20Illinois%20Department%20of%20Financial,collaborative%20agreement%20following%20a%20TTP
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20DEA%20gave%20us%20the,evaluation%20at%20the%20federal%20level
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=Despite%20federal%20DEA%20waivers%20extending,traps%20for%20digital%20health%20providers
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=1.%20Florida%3A%20The%20%22No,for%20Stimulants
• https://www.mondaq.com/unitedstates/healthcare/1447512/a-changing-regulatory-and-reimbursement-landscape-for-weight-loss-drugs#:~:text=New%20Jersey%20law%20requires%20that,and%20identify%20the%20risks%20associated
• https://drlewis.com/glp-1-medications-psychiatry/#:~:text=You%20know%20these%20drugs,disorders%2C%20and%20possibly%20depression%20itself
• https://drlewis.com/glp-1-mental-health/#:~:text=Now%20let%E2%80%99s%20talk%20about%20potential,where%20things%20get%20really%20interesting